Biosensor-based diagnostic approaches for various cellular biomarkers of breast cancer: A comprehensive review
- PMID: 33080213
- DOI: 10.1016/j.ab.2020.113996
Biosensor-based diagnostic approaches for various cellular biomarkers of breast cancer: A comprehensive review
Abstract
Breast cancer is the most commonly occurring cancer among women which leads to thousands of deaths worldwide. The chances of survival are more if the breast cancer is diagnosed at early stage. At present, mammography, magnetic resonance imaging, ultrasound and tissue biopsies are the main diagnostic techniques available for the detection of breast cancer. However, despite of offering promising results, requirement of expensive setup, skilled supervision, expert analysis, invasive procedure (biopsy) and low capacity of multiplexing are the main limitations of these diagnostic techniques. Due to high cost, these screening tests are out of reach of people belonging to low socioeconomic groups and this poses serious health burden to the society. Recently, biosensor-based diagnostic technology for early detection of various types of cancers and other non-oncological disorders have gained considerable attention because of their several advantageous features over existing diagnostic technologies such as high throughput, noninvasive nature, cost effectiveness, easy interpretable results and capacity for multiplexing. Further, biosensors can be designed for biomarkers which are confined to particular type of cancer. In this review, we have discussed about various genomic, transcriptomic, proteomic and metabolomic biomarkers associated with breast cancer, various biosensors-based diagnostic approaches designed for detection of specific biomarkers associated with breast cancer are also described. Further, this review throws insight on various biomarkers linked with breast cancer which can be effectively exploited to develop new diagnostic technology. The assessment of these biomarkers associated with BC using biosensors in large population are cost-effective, non-invasive and high throughput. They help in risk assessment of disease at very initial stage even in backward areas and also help to lower the disease burden of society and economic cost of treatment for a common man. This review would provide new avenues for the development of biosensor based diagnostic technology for the detection of biomarkers associated with breast cancer.
Keywords: Biosensor; Breast cancer; Breast cancer biomarkers; Electrochemical; Microfluidics; Optical.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Advances in Electrochemical Biosensor Technologies for the Detection of Nucleic Acid Breast Cancer Biomarkers.Sensors (Basel). 2023 Apr 20;23(8):4128. doi: 10.3390/s23084128. Sensors (Basel). 2023. PMID: 37112468 Free PMC article. Review.
-
Electrochemical biosensors for early detection of breast cancer.Clin Chim Acta. 2025 Jan 1;564:119923. doi: 10.1016/j.cca.2024.119923. Epub 2024 Aug 15. Clin Chim Acta. 2025. PMID: 39153652 Review.
-
A new insight into the early detection of HER2 protein in breast cancer patients with a focus on electrochemical biosensors approaches: A review.Int J Biol Macromol. 2024 Jun;272(Pt 1):132710. doi: 10.1016/j.ijbiomac.2024.132710. Epub 2024 May 31. Int J Biol Macromol. 2024. PMID: 38825266 Review.
-
Proteomic-based electrochemical non-invasive biosensor for early breast cancer diagnosis.Int J Biol Macromol. 2023 Dec 31;253(Pt 4):126681. doi: 10.1016/j.ijbiomac.2023.126681. Epub 2023 Sep 2. Int J Biol Macromol. 2023. PMID: 37666403
-
Recent advances in nanomaterials-based electrochemical immunosensors and aptasensors for HER2 assessment in breast cancer.Mikrochim Acta. 2021 Sep 2;188(10):317. doi: 10.1007/s00604-021-04963-2. Mikrochim Acta. 2021. PMID: 34476602 Review.
Cited by
-
HER-2-Targeted Electrochemical Sensors for Breast Cancer Diagnosis: Basic Principles, Recent Advancements, and Challenges.Biosensors (Basel). 2025 Mar 25;15(4):210. doi: 10.3390/bios15040210. Biosensors (Basel). 2025. PMID: 40277524 Free PMC article. Review.
-
Impact of Nanomedicine in Women's Metastatic Breast Cancer.Small. 2024 Oct;20(41):e2301385. doi: 10.1002/smll.202301385. Epub 2023 Jun 3. Small. 2024. PMID: 37269217 Free PMC article. Review.
-
Characteristics of P-Type and N-Type Photoelectrochemical Biosensors: A Case Study for Esophageal Cancer Detection.Nanomaterials (Basel). 2021 Apr 21;11(5):1065. doi: 10.3390/nano11051065. Nanomaterials (Basel). 2021. PMID: 33919216 Free PMC article.
-
From Biosensors to Robotics: Pioneering Advances in Breast Cancer Management.Sensors (Basel). 2024 Sep 23;24(18):6149. doi: 10.3390/s24186149. Sensors (Basel). 2024. PMID: 39338894 Free PMC article. Review.
-
Functional Ionic Liquids Decorated Carbon Hybrid Nanomaterials for the Electrochemical Biosensors.Biosensors (Basel). 2021 Oct 23;11(11):414. doi: 10.3390/bios11110414. Biosensors (Basel). 2021. PMID: 34821629 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous